Evaluation of HemoTypeSC as a Novel Rapid Test for Point-of-Care Screening for Sickle-Cell Disease, Hemoglobin C Disease, and Carrier Status in Low-Resource Settings
- Conditions
- Diagnoses Disease
- First Posted Date
- 2018-08-08
- Last Posted Date
- 2018-08-08
- Lead Sponsor
- Silver Lake Research Corporation
- Target Recruit Count
- 600
- Registration Number
- NCT03619798
- Locations
- 🇺🇸
Silver Lake Research Corporation, Azusa, California, United States
© Copyright 2025. All Rights Reserved by MedPath